Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 6 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
6(100.0%)
6Total
N/A(6)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT05270512Not ApplicableCompleted

Evaluation of the Dermal Cooling System for Treatment of Common Skin Conditions

Role: lead

NCT03282994Not ApplicableCompleted

Dermal Cooling System for Cryotherapy of Common Skin Conditions

Role: lead

NCT04493021Not ApplicableCompleted

Evaluation of the Dermal Cooling System for the Enhanced Treatment of Benign Pigmented Lesions and Common Skin Conditions

Role: lead

NCT02848742Not ApplicableCompleted

Dermal Cryotherapy for Treatment of Pigmented Lesions

Role: lead

NCT02763306Not ApplicableCompleted

Dermal Cryotherapy in Patients Undergoing Abdominoplasty

Role: lead

NCT02744794Not ApplicableCompleted

Evaluation of a New Dermal Cryotherapy System

Role: lead

All 6 trials loaded